Interestingly, blocking of IL-10 in CLL’s PBMC cultures could decrease the CLL cells viability for samples previously displaying high survival of CLL cells, and further decrease survival in initially low viability cultures, especially upon additional treatment with TNF. The gene discussed is IL10; the disease is B-cell chronic lymphocytic leukemia.